Substituted heteroaryl compounds and methods of use
US9403801B2 · kind B2 · utility
2Cited by
24References
27Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 27, 2015 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Mar 27, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof useful in preventing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.